Cargando…
Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
IMPORTANCE: Germline CHEK2 pathogenic variants (PVs) are frequently detected by multigene cancer panel testing (MGPT), but our understanding of PVs beyond c.1100del has been limited. OBJECTIVE: To compare cancer phenotypes of frequent CHEK2 PVs individually and collectively by variant type. DESIGN,...
Autores principales: | Bychkovsky, Brittany L., Agaoglu, Nihat B., Horton, Carolyn, Zhou, Jing, Yussuf, Amal, Hemyari, Parichehr, Richardson, Marcy E., Young, Colin, LaDuca, Holly, McGuinness, Deborah L., Scheib, Rochelle, Garber, Judy E., Rana, Huma Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501803/ https://www.ncbi.nlm.nih.gov/pubmed/36136322 http://dx.doi.org/10.1001/jamaoncol.2022.4071 |
Ejemplares similares
-
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023) -
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023) -
The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study
por: Alorjani, Mohammed, et al.
Publicado: (2023) -
Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006) -
CHEK2 mutations in pediatric brain tumors
por: Tlais, Dana, et al.
Publicado: (2023)